Insider Transactions in Q3 2025 at Schwab Charles Corp (SCHW)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.54%
|
$2,304,000
$96.64 P/Share
|
|
Sep 02
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,205
-7.78%
|
$304,475
$95.2 P/Share
|
|
Aug 28
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
6,144
-34.01%
|
$589,824
$96.81 P/Share
|
|
Aug 28
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
6,144
+12.42%
|
$282,624
$46.39 P/Share
|
|
Aug 27
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
3,296
-21.66%
|
$319,712
$97.18 P/Share
|
|
Aug 27
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Open market or private sale
|
Direct |
50,016
-100.0%
|
$4,851,552
$97.0 P/Share
|
|
Aug 27
2025
|
Peter J. Morgan Iii General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
50,016
+49.44%
|
$2,750,880
$55.24 P/Share
|
|
Aug 27
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
136,500
-0.24%
|
$13,240,500
$97.04 P/Share
|
|
Aug 26
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
136,500
-0.24%
|
$13,104,000
$96.67 P/Share
|
|
Aug 25
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
13,542
-0.92%
|
$1,300,032
$96.06 P/Share
|
|
Aug 08
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
133,153
-0.12%
|
$12,782,688
$96.72 P/Share
|
|
Aug 07
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
22,721
-0.04%
|
$2,181,216
$96.02 P/Share
|
|
Aug 07
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-0.75%
|
$2,304,000
$96.95 P/Share
|
|
Aug 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-7.4%
|
$315,840
$96.06 P/Share
|
|
Jul 29
2025
|
Walter W Bettinger Co-Chairman |
SELL
Open market or private sale
|
Indirect |
173,876
-22.74%
|
$17,039,848
$98.84 P/Share
|
|
Jul 29
2025
|
Richard A Wurster President & CEO |
SELL
Open market or private sale
|
Direct |
20,500
-11.54%
|
$2,029,500
$99.16 P/Share
|
|
Jul 29
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
24,096
-29.0%
|
$2,337,312
$97.91 P/Share
|
|
Jul 29
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,096
+22.48%
|
$987,936
$41.98 P/Share
|
|
Jul 29
2025
|
Joan Dea Director |
SELL
Bona fide gift
|
Direct |
513
-1.82%
|
-
|
|
Jul 03
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.48%
|
$2,184,000
$91.59 P/Share
|
|
Jul 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-2.33%
|
$93,150
$90.74 P/Share
|
|
Jul 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-8.4%
|
$296,100
$90.95 P/Share
|